Evidence map›Paper›PMID 36343033›Full record

ArticleMedicine2022

Enhancement of fluoride release in glass ionomer cements modified with titanium dioxide nanoparticles.

Adriana Alejandra Morales-Valenzuela, Rogelio José Scougall-Vilchis, Edith Lara-Carrillo, Rene Garcia-Contreras, Wael Hegazy-Hassan, Víctor Hugo Toral-Rizo, Elias Nahum Salmerón-Valdés

Open access · goldAbstract read
In one paragraph

Article in Medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Effect of Titanium Dioxide (TiOMaterials (Basel, Switzerland) · 2026
    Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Adriana Alejandra Morales-ValenzuelaCentro de Investigación y Estudios Avanzados en Odontología "Dr. Keisaburo Miyata," Facultad de Odontología, Universidad Autónoma del Estado de México. Paseo Tollocan esq. Jesús Carranza, Col. Universidad, CP 50130. Toluca, Estado de México, México.
Rogelio José Scougall-VilchisCentro de Investigación y Estudios Avanzados en Odontología "Dr. Keisaburo Miyata," Facultad de Odontología, Universidad Autónoma del Estado de México. Paseo Tollocan esq. Jesús Carranza, Col. Universidad, CP 50130. Toluca, Estado de México, México.
Edith Lara-CarrilloCentro de Investigación y Estudios Avanzados en Odontología "Dr. Keisaburo Miyata," Facultad de Odontología, Universidad Autónoma del Estado de México. Paseo Tollocan esq. Jesús Carranza, Col. Universidad, CP 50130. Toluca, Estado de México, México.
Rene Garcia-ContrerasUniversidad Nacional Autónoma de México. Blv. UNAM 2011, Col. Predio del Saucillo y el Potrero, Comunidad de los Tepetates, Leon CP 37684, Guanajuato, México.
Wael Hegazy-HassanCentro de Investigación y Estudios Avanzados en Odontología "Dr. Keisaburo Miyata," Facultad de Odontología, Universidad Autónoma del Estado de México. Paseo Tollocan esq. Jesús Carranza, Col. Universidad, CP 50130. Toluca, Estado de México, México.
Víctor Hugo Toral-RizoCentro de Investigación y Estudios Avanzados en Odontología "Dr. Keisaburo Miyata," Facultad de Odontología, Universidad Autónoma del Estado de México. Paseo Tollocan esq. Jesús Carranza, Col. Universidad, CP 50130. Toluca, Estado de México, México.
Elias Nahum Salmerón-ValdésCentro de Investigación y Estudios Avanzados en Odontología "Dr. Keisaburo Miyata," Facultad de Odontología, Universidad Autónoma del Estado de México. Paseo Tollocan esq. Jesús Carranza, Col. Universidad, CP 50130. Toluca, Estado de México, México.ORCID 0000-0001-6732-6388
Universidad Autónoma del Estado de México · MXUniversidad Nacional Autónoma de México · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSeveral efforts have been made to improve the glass ionomer cements (GICs) properties with nanotechnology. Fluoride release in once of most beneficial properties of GICs. The purpose of this study was to evaluate the fluoride release, recharge, and cytotoxicity in GICs reinforced with titanium dioxide nanoparticles (TiO2N).

objectiveEvaluate the fluoride release, recharge, and cytotoxicity in GICs reinforced with TiO2N.

methodsFour GICs, FUJI IX EXTRA (G1c), KETAC MOLAR (G2c), IONOFILL MOLAR (G3c), and FUJI IX (G4c) were combined with TiO2N (G1e, G2e, G3e, and G4e) and divided into blocks of 5-mm width and 1-mm thickness 10 each. A total of 80 samples were arranged as follows: GICs alone as negative control (n = 40) and GICs + TiO2N as experimental groups (n = 40). The fluoride release was determined for periods of 1, 2, 6, 10, 31, 90, 180, 240, and 300 days. On days 30 and 179, samples were recharged by submerging in 1 mL of 20,000 ppm sodium fluoride gel. Cytotoxic activity was carried out with gingival fibroblasts, using 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide cell viability assay.

resultsThe experimental groups obtained the highest and more constant fluoride released when compared to control groups. After the first recharge, experimental groups (G1e, G3e, and G4e) showed statistically significant results (P = .001, 0.010, and 0.001 respectively) enhancing their recharge ability regarding control groups. The second recharge showed better results in G1e concerning the rest of the groups. No cytotoxic activity was observed in all experimental groups, although significant differences were observed in G3e and G4e regarding control group.

conclusionThe incorporation of TiO2N enhance the fluoride release in glass ionomers with a noncytotoxic effect on human gingival fibroblasts.

Indexed as

FluoridesNanoparticlesGlass Ionomer CementsHumansMaterials TestingTitaniumFluoridesGlass Ionomer CementsTitaniumtitanium dioxide

Identifiers

PMID36343033
PMCPMC9646495
OpenAlexW4308408714

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.